Muzaffar H Qazilbash
M.D. Anderson Cancer Center · UT MD Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Muzaffar H Qazilbash as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:10 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03622775 · Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell TransplantM.D. Anderson Cancer Center · terminated · Recurrent Plasma Cell Myeloma · principal investigator
- Ph2NCT01426828 · Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing TransplantUniversity of Pennsylvania · completed · Multiple Myeloma · principal investigator
- Ph3NCT01413178 · A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple MyelomaM.D. Anderson Cancer Center · completed · Myeloma · principal investigator
- Ph2NCT01174082 · Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic TransplantM.D. Anderson Cancer Center · terminated · Myeloma · principal investigator
- Ph1/Ph2NCT01079936 · Lenalidomide and High-Dose MelphalanM.D. Anderson Cancer Center · completed · Myeloma, Stem Cell Transplantation · study chair
- Ph1NCT00866346 · PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic TransplantationM.D. Anderson Cancer Center · withdrawn · Chronic Myelogenous Leukemia · principal investigator
- Ph1/Ph2NCT00661544 · Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma PatientsM.D. Anderson Cancer Center · completed · Multiple Myeloma, Stem Cell Transplantation · principal investigator
- Ph2NCT00505895 · FM 140 vs FM100 Study in Patients With Multiple MyelomaM.D. Anderson Cancer Center · completed · Multiple Myeloma · principal investigator
- Ph1/Ph2NCT00469209 · Velcade, Trisenox, Vitamin C and Melphalan for Myeloma PatientsM.D. Anderson Cancer Center · completed · Myeloma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in multiple myeloma, ranked by citations from NIH iCite, fetched 2026-11-12 12:10 UTC. The ranking covers the 200 most relevant of 24 PubMed records, and a shared surname and initials can bring in a namesake. All 24 on PubMed
- Lenalidomide after stem-cell transplantation for multiple myeloma.N Engl J Med · 2012918 citationsRCR 24.3
- 221 citationsRCR 5.2
- Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.J Clin Oncol · 2019219 citationsRCR 8.5
- 151 citationsRCR 4.7
- Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial.Lancet Haematol · 201975 citationsRCR 3.1
- 65 citationsRCR 6.6
- 62 citationsRCR 1.4
- Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.Biol Blood Marrow Transplant · 200957 citationsRCR 1.5
- Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.Br J Haematol · 200640 citationsRCR 1.1
- Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.Biol Blood Marrow Transplant · 200838 citationsRCR 1.0